Statistics for Economic Outcomes in Patients With Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer Treated With Enzalutamide or Abiraterone Acetate Plus Prednisone

Total visits

views
Economic Outcomes in Patients With Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer Treated With Enzalutamide or Abiraterone Acetate Plus Prednisone 64

Total visits per month

views
August 2025 0
September 2025 1
October 2025 2
November 2025 0
December 2025 0
January 2026 0
February 2026 0

File Visits

views
Ramaswamy2020_Article_EconomicOutcomesInPatientsWith.pdf 20

Top country views

views
United States 23
China 6
Germany 2
France 2
United Kingdom 2
Hong Kong SAR China 2
Italy 2
Austria 1
Belgium 1
South Korea 1
Pakistan 1
Saudi Arabia 1
Sweden 1
Slovenia 1

Top city views

views
Central 2
Ancona 1
Asheville 1
Batavia 1
Columbus 1
Dammam 1
Detroit 1
Kaiserslautern 1
Oberhaslach 1
Phoenix 1
Qingdao 1
San Diego 1
Shenyang 1
Shenzhen 1
The Dalles 1
Wieting 1
Évreux 1